SCHEMBL3047464

SCHEMBL3047464

CNC(=O)C(C)(C)NC(=O)c1ncc(-c2ccccc2Cl)cc1O

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 14/20 0.62
EGLN3 Q9H6Z9 9/20 0.62
VEGFA P15692 7/20 0.62
FLT1 P17948 7/20 0.62
PAK1 Q13153 1/20 0.41
CNR2 P34972 2/20 0.39
TET3 O43151 1/20 0.39
BBOX1 O75936 1/20 0.39
ASPH Q12797 1/20 0.39
TET2 Q6N021 1/20 0.39
KDM8 Q8N371 1/20 0.39
OGFOD1 Q8N543 1/20 0.39
TET1 Q8NFU7 1/20 0.39
HIF1AN Q9NWT6 1/20 0.39
USP7 Q93009 1/20 0.39
DEGS1 O15121 1/20 0.38
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
FTO Q9C0B1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3048516 0.88 EGLN1 (0.63) EGLN1EGLN3VEGFAFLT1PAK1
SCHEMBL1920959 0.82 EGLN1 (0.65) EGLN1EGLN3VEGFAFLT1CNR2
SCHEMBL30239261 0.82 EGLN1 (0.65) EGLN1EGLN3VEGFAFLT1CNR2
SCHEMBL3047467 0.82 EGLN1 (0.50) EGLN1EGLN3VEGFAFLT1PAK1
SCHEMBL3041651 0.81 EGLN1 (0.62) EGLN1EGLN3VEGFAFLT1CNR2
SCHEMBL3484350 0.79 EGLN1 (0.58) EGLN1EGLN3VEGFAFLT1TET3
SCHEMBL14331206 0.78 EGLN1 (0.57) EGLN1EGLN3VEGFAFLT1
SCHEMBL30287600 0.76 EGLN1 (1.00) EGLN1EGLN3VEGFAFLT1TET3
SCHEMBL1921063 0.76 EGLN1 (1.00) EGLN1EGLN3VEGFAFLT1TET3
SCHEMBL3485494 0.76 PIK3CD (0.47) EGLN1EGLN3VEGFAFLT1TET3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044005-B1 PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE WARNER CHILCOTT CO LLC (PR) 2010-10-20 EP disclosed
US-7811595-B2 such as {[5-(3-Chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester; for controlling Peripheral Vascular Disease, Coronary Artery Disease, heart failure, ischemia, and anemia WARNER CHILCOTT COMPANY, LLC (US) 2010-10-12 US disclosed